Photodynamic therapy (PDT) for lung cancers

Area of Science:

• Oncology
• Photomedicine

Background:

• Photodynamic therapy (PDT) is an established cancer treatment using photosensitizers and laser light.
• PDT is approved for early-stage, centrally located lung cancer in several countries.
• PDT offers lung function preservation, repeatability, and combination therapy potential.

Purpose of the Study:

• To review recent clinical trials of PDT for early lung cancer.
• To explore new PDT applications for peripheral and advanced lung cancers.
• To discuss combined PDT treatment strategies for lung cancer.

Main Methods:

• Review of clinical trials and recent advancements in PDT for lung cancer.
• Focus on second-generation photosensitizers like mono-l-aspartyl chlorine e6 (NPe6).
• Discussion of diode laser applications and combined therapeutic modalities.

Main Results:

• NPe6 demonstrated excellent antitumor effects with low photosensitivity in a phase II study.
• PDT shows promise for both central and peripheral early-stage lung cancers.
• Combined PDT approaches are being investigated for advanced lung cancer.

Conclusions:

• PDT is a viable and evolving treatment for lung cancer, particularly early stages.
• Newer photosensitizers and technologies are improving PDT efficacy and tolerability.
• The scope of PDT applications in lung cancer treatment is expanding.